Physician profile
David S Cho
NPI 1033103445
$26,366.12
in general payments reported to CMS, 2019-2025
68 companies · $3,971 in 2025
The $3,971 reported for 2025 was more than what 97% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,086 · 2020: $2,848 · 2021: $4,276 · 2022: $3,601 · 2023: $4,533 · 2024: $4,050 · 2025: $3,971.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $13K · Education: $45.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $12,509.23 |
| Education | $45.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $3,211.85 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Abbvie INC. | $2,962.98 | 2019-2025 | Qulipta, Ubrelvy, Vraylar |
| Glaxosmithkline, LLC. | $2,922.19 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Novo Nordisk INC | $2,357.81 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $1,845.24 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Pfizer INC. | $1,692.85 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,146.63 | 2019-2025 | Jardiance, Synjardy, Tradjenta |
| Janssen Pharmaceuticals, INC | $1,104.89 | 2019-2023 | Xarelto |
| Bayer Healthcare Pharmaceuticals INC. | $861.78 | 2021-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $652.04 | 2020-2025 | Xifaxan, Trulance |
| Novartis Pharmaceuticals Corporation | $624.76 | 2019-2025 | |
| Kowa Pharmaceuticals America, INC. | $584.58 | 2019-2024 | Livalo, Seglentis, Zoryve |
| Amarin Pharma, INC. | $499.65 | 2019-2022 | |
| Amgen INC. | $499.16 | 2019-2025 | Otezla, Repatha, Repatha |
| Merck Sharp & Dohme LLC | $479.34 | 2019-2025 | Capvaxive, Gardasil 9, Gardasil |
Show all 68 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $378.02 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Esperion Therapeutics, INC. | $368.11 | 2020-2025 | Nexletol |
| Astellas Pharma US INC | $362.11 | 2022-2024 | Veozah, Myrbetriq |
| Abbott Laboratories | $322.17 | 2019-2025 | Freestyle Libre 3 |
| E.R. Squibb & Sons, L.L.C. | $295.60 | 2019-2023 | Eliquis, Camzyos |
| Axsome Therapeutics, INC. | $254.26 | 2023-2025 | Sunosi, Auvelity |
| Lundbeck LLC | $188.65 | 2022-2025 | Rexulti |
| Otsuka America Pharmaceutical, INC. | $180.91 | 2021-2025 | Rexulti |
| Endo Pharmaceuticals INC. | $167.60 | 2019-2020 | |
| Mylan Specialty L.P. | $148.79 | 2019-2023 | Yupelri |
| Axogen | $140.00 | 2021 | |
| Ironwood Pharmaceuticals, INC | $134.61 | 2021-2023 | Linzess |
| Sanofi-Aventis U.S. LLC | $132.80 | 2019-2024 | |
| Allergan, INC. | $114.14 | 2019-2020 | |
| Djo, LLC | $109.53 | 2025 | Cmf |
| Alexion Pharmaceuticals, INC. | $98.71 | 2023-2025 | Strensiq |
| Arbor Pharmaceuticals, INC. | $96.30 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $93.26 | 2019-2020 | |
| Dexcom, INC. | $80.11 | 2023 | Dexcom G6 Transmitter |
| Ibsa Pharma INC. | $79.60 | 2019-2021 | |
| Csl Behring | $79.31 | 2022-2024 | Hizentra |
| Scilex Pharmaceuticals INC. | $78.45 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $76.22 | 2019-2022 | |
| Eisai INC. | $70.28 | 2023-2024 | |
| Biogen, INC. | $59.54 | 2021 | |
| Coloplast Corp | $58.13 | 2025 | |
| Idorsia Pharmaceuticals US INC | $55.15 | 2023 | Quviviq |
| Insulet Corporation | $53.14 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $49.07 | 2021 | |
| Kyowa Kirin, INC. | $47.14 | 2022-2025 | |
| Daiichi Sankyo INC. | $40.69 | 2021 | |
| Boston Scientific Corporation | $33.61 | 2025 | Watchman Flx |
| Ucb, INC. | $31.72 | 2024 | Nayzilam |
| Paratek Pharmaceuticals, INC. | $31.15 | 2021-2022 | |
| Alnylam Pharmaceuticals INC. | $28.86 | 2022 | |
| Irhythm Technologies, INC. | $28.77 | 2024 | Zio Monitor, Zio Xt Patch |
| Sanofi Pasteur INC. | $28.51 | 2019 | |
| Inspire Medical Systems, INC. | $28.24 | 2025 | Inspire |
| Medtronic USA, INC. | $26.51 | 2019 | |
| Optinose US, INC. | $26.48 | 2024 | |
| Cleerly, INC. | $25.07 | 2024 | Cleerly Labs, Cleerly Ischemia |
| Adamas Pharmaceuticals, INC. | $22.65 | 2021 | |
| Collegium Pharmaceutical, INC. | $22.02 | 2024 | Xtampza |
| Genzyme Corporation | $21.45 | 2023 | |
| Leo Pharma INC. | $21.15 | 2019 | |
| Sun Pharmaceutical Industries INC. | $20.89 | 2019 | |
| Amneal Pharmaceuticals LLC | $20.11 | 2021 | |
| Medtronic Vascular, INC. | $18.27 | 2020 | |
| Rgh Enterprises LLC | $17.12 | 2024 | |
| Medtronic, INC. | $15.61 | 2021 | |
| Vbi Vaccine (Delaware) INC. | $15.17 | 2022 | |
| Currax Pharmaceuticals LLC | $12.98 | 2023 | Contrave |
| Alfasigma USA, INC. | $11.63 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Cho listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.